Liga, Remelyne A.
HRN: 22-03-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
CEFUROXIME 1.5GM (VIAL)
11/21/2022
11/22/2022
IVT
1.5gms
Q8H
S/P LTCS With Intra CS IUD
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes